🔎 Trials Near Me

Dachaigh › Obesity › Minnesota

Sgrùdaidhean clionaigeach Obesity ann an Minnesota

Tha 29 sgrùdaidhean airson Obesity a’ lorg phàirtichean aig làraichean ann an Minnesota.

Bailtean ann an Minnesota

Teacsa sgrùdaidh oifigeil (Beurla)

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

  • International Diabetes Center, Minneapolis
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT07533175

A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

  • International Diabetes Center, Minneapolis
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT07564414

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

  • University of Minnesota, Minneapolis
  • Synexus Clinical Research US-MN, Richfield
A’ fastadhÌre 3
Aoisean 8 gu 18 · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT07253285

A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)

  • Headlands Research - Twin Cities, Maplewood
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT07823608

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

  • University of Minnesota Masonic Children's Hospital, Minneapolis
  • Mayo Clinic - PIN, Rochester
  • Children's Minnesota Pediatric Endocrinology Clinic & McNeeley Diabetes Center, Saint Paul
A’ fastadhÌre 3
Aoisean 6 gu 17 · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT06672549

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

  • Headlands Research-Twin Cities, Maplewood
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07369011

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  • Fairview Health Services M Health Fairview St Johns Hospital, Maplewood
  • Minneapolis Heart Institute Foundation, Minneapolis
A’ fastadhÌre 3
Aoisean 45 gu 99 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07037433

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

  • AURORA-2 Clinical Site, Mankato
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT07743450

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  • Mankato Clinic, Mankato
  • Fairview Health Services M Health Fairview St Johns Hospital, Maplewood
  • University of Minnesota, Minneapolis
A’ fastadhÌre 3
Aoisean 18 gu 99 · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT07037459

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

  • International Diabetes Center At Park Nicollet, Minneapolis
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT07351045

First-in-human Study of the Safety, Tolerability, Pharmacokinetics, and Food Effect of ACCG-2671

  • Research Site, Dilworth
A’ fastadhÌre 1/2Fàilte do shaor-thoilich fhallain
Aoisean 25 gu 75 · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT07815678

Exercise Response in Humans With Obesity

  • Mayo Clinic in Rochester, Rochester
A’ fastadhSgrùdadh amharc
Aoisean 20 gu 45 · Gach gnè · Air ùrachadh 11 Sult 2026 · NCT05857150

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

  • ACCOMPLISH-2 Research Site, Mankato
  • ACCOMPLISH-2 Research Site, Minneapolis
A’ fastadhÌre 3Fàilte do shaor-thoilich fhallain
Aoisean 18 gu 79 · Gach gnè · Air ùrachadh 11 Sult 2026 · NCT07654374

tDCS With Cognitive Training to Reduce Impulsivity and Weight in Veterans With Obesity

  • Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis
A’ fastadh
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT05225233

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

  • Children's Hospitals and Clinics of Minnesota, Minneapolis
A’ fastadhÌre 2
Aoisean 7 gu 25 · Gach gnè · Air ùrachadh 19 Lùna 2026 · NCT05082519

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

  • ACCOMPLISH-1 Research Site, Mankato
  • ACCOMPLISH-1 Research Site, Richfield
A’ fastadhÌre 3
Aoisean 18 gu 79 · Gach gnè · Air ùrachadh 10 Lùna 2026 · NCT07654361

Upper Body Subcutaneous Exosome Release in Response to a Meal in Obesity

  • Mayo Clinic in Rochester, Rochester
A’ fastadhFàilte do shaor-thoilich fhallain
Aoisean 18 gu 55 · Gach gnè · Air ùrachadh 5 Lùna 2026 · NCT07031297

Fibrosis Lessens After Metabolic Surgery

  • Mayo Clinic, Rochester
A’ fastadhÌre 4Fàilte do shaor-thoilich fhallain
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 31 Iuch 2026 · NCT06374875

A Proof-of-Concept Study to Evaluate Topical-Lingual Semaglutide in Adults With Obesity

  • Clinical Research Institute of Minnesota, Minneapolis
A’ fastadhÌre 4
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 27 Iuch 2026 · NCT07728383

Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention

  • Minneapolis VA Health Care System, Minneapolis
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Iuch 2026 · NCT06390345

Phenotype-Tailored Lifestyle Intervention for Obesity: A Randomized Trial

  • Mayo Clinic, Rochester
A’ fastadh
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 11 Ògmh 2026 · NCT06770049

Regional Lipolysis and Adipocyte Lipolysis Protein Stimulation

  • Mayo Clinic in Rochester, Rochester
A’ fastadhÌre 1 tràthFàilte do shaor-thoilich fhallain
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 22 Cèit 2026 · NCT06416969

Circadian Rhythms in Human Adipose

  • Mayo Clinic, Rochester
A’ fastadhFàilte do shaor-thoilich fhallain
Aoisean 18 gu 55 · Gach gnè · Air ùrachadh 14 Gibl 2026 · NCT06891534

Regional Lipolysis Insulin Regulation

  • Mayo Clinic in Rochester, Rochester
A’ fastadhÌre 1 tràthFàilte do shaor-thoilich fhallain
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 13 Gibl 2026 · NCT06392854

Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder

  • Mayo Clinic, Rochester
A’ fastadhÌre 4A’ toirt iomradh air pàigheadh do chom-pàirtichean
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 11 Màrt 2026 · NCT07213466

Insulin Regulation of Lipolysis and Lipolysis Proteins

  • Mayo Clinic in Rochester, Rochester
A’ fastadhÌre 1 tràthFàilte do shaor-thoilich fhallain
Aoisean 18 gu 55 · Gach gnè · Air ùrachadh 28 Faoi 2026 · NCT03866408

Project SHINE (Sleep Health INitiative for Equity): Culturally Informing a Sleep Extension Intervention for African American Adults

  • University of Minnesota, Minneapolis
A’ fastadhÌre 1/2
Aoisean 21 gu 75 · Gach gnè · Air ùrachadh 17 Dùbh 2025 · NCT06226077

Weight Loss Through Mayo Clinic Diet

  • Mayo Clinic in Rochester, Rochester
A’ fastadhFàilte do shaor-thoilich fhallain
Aoisean 18 gu 64 · Gach gnè · Air ùrachadh 7 Dàmh 2025 · NCT06862375

Tirzepatide in PWS, HO and GNSO

  • Children's Minnesota, Saint Paul
A’ fastadhÌre 4
Aoisean 18 gu 26 · Gach gnè · Air ùrachadh 16 Sult 2025 · NCT06901245

Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.